Ironwood Pharmaceuticals
Focus: Ironwood Pharmaceuticals is a specialty pharmaceutical company focused on small-molecule therapies in gastrointestinal and metabolic disease, headquartered in Boston with marketed products in peak lifecycle stages.
Profile data last refreshed 17h ago · AI intelligence enriched 2w ago
Open Jobs
3+1 this month
Stable — net +1 jobs in 30d
2 added, 1 removed. Backfill posture.
Should You Work at Ironwood Pharmaceuticals?
AI assessmentIronwood is a stable, product-focused specialty pharma with meaningful pipeline depth but constrained hiring and recent leadership turnover; best fit for candidates seeking a mature GI-focused organization rather than rapid growth.
Why Work Here
- Two marketed products (ZURAMPIC and DUZALLO) in peak lifecycle with patent protection until 2032, providing revenue stability for R&D investment.
Data completeness
6/9 — Partial
Company HealthStrong
Pipeline
Late-stage
15 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Ironwood Pharmaceuticals
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.